openPR Logo
Press release

Respiratory Inhaler Devices Market Size Analysis, DROT, PEST, Porter’s, Region & Country Forecast Till 2027

08-10-2021 02:58 PM CET | Health & Medicine

Press release from: Reports And Data

Respiratory Inhaler Devices Market

Respiratory Inhaler Devices Market

The global respiratory inhaler devices market is expected to reach a market size of USD 52.43 Billion by 2027, and register a high CAGR during the forecast period, according to a new report by Reports and Data.

The respiratory inhaler devices market is driven by increase in the incidence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Players in the market are investing in the development of advanced portable inhalation devices that will also fuel growth of the market.
Respiratory diseases is among the leading cause of death and disability globally. According to the World Health Organization, around 65 million people suffer from chronic obstructive pulmonary disease, and 3 million die every year, making it the third leading cause of death.

Rise in trend of smart respiratory inhaler devices will drive growth of the market in the coming years. Smart inhaler devices are designed to connect with mobile application and help users to monitor dosage reminders and medication schedules. However, high cost of respiratory inhaler devices will hinder growth of the market.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3770

The report provides a panoramic view of the market and insights that will help formulate better business decisions. In addition to that, the study helps well-established companies and players gain a deeper understanding of the market and make informed decisions. The report also discusses in detail about the key factors influencing the market growth.

Key companies operating in the market include:

AstraZeneca, Cipla Ltd., Merck & Co., Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Medisol Lifescience Pvt. Ltd., Koninklijke Philips N.V., Novartis AG, Philips Healthcare, and 3M.

The report covers an extensive analysis of the key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3770

The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global Respiratory Inhaler Devices market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region.

On basis of product types and application offered by the Respiratory Inhaler Devices industry, the market is segmented into:

Product Type Outlook (Revenue, USD Billion; 2017-2027)
• Dry Powder Inhaler
• Metered Dose Inhaler
• Nebulizer
o Compressed Air Nebulizer
o Ultrasonic Nebulizer
o Mesh Nebulizer

Mode of Operation Outlook (Revenue, USD Billion; 2017-2027)
• Digitally Operated Inhaler Devices
• Manually Operated Inhaler Devices

Application Outlook (Revenue, USD Billion; 2017-2027)
• Chronic Obstructive Pulmonary Disease
• Asthma
• Pulmonary Arterial Hypertension
• Others

The regional analysis covers:
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o Italy
o France
o BENELUX
o Rest of Europe
• Asia Pacific
o China
o India
o Japan
o South Korea
o Rest of APAC
• Latin America
o Brazil
o Rest of LATAM
• Middle East & Africa
o Saudi Arabia
o U.A.E.
o South Africa
o Rest of MEA

To know more about the report @ https://www.reportsanddata.com/report-detail/respiratory-inhaler-devices-market

Benefits of Respiratory Inhaler Devices Market Report:
• Panoramic overview of the opportunities and risks in the Respiratory Inhaler Devices sector
• Study of recent innovations and developments in the industry
• Comprehensive study of the growth pattern of the Respiratory Inhaler Devices industry
• In-depth assessment of the competitive landscape of the key players of the Respiratory Inhaler Devices industry
• Analysis of the Respiratory Inhaler Devices market drivers, constraints, and opportunities
• Assessment of technological developments and latest trends of the industry

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3770

Thank you for reading our report. For customization or further inquiry, please get in touch with us. Our team will ensure the report is tailored according to your requirements.

Browse More Reports

Vaginal Pessary Market@https://www.reportsanddata.com/report-detail/vaginal-pessary-market

Spinal Trauma Devices Market@https://www.reportsanddata.com/report-detail/spinal-trauma-devices-market

Wearable Healthcare/Medical Devices Market @ https://www.reportsanddata.com/report-detail/wearable-healthcare-medical-devices-market

Artificial Joints Market@https://www.reportsanddata.com/report-detail/artificial-joints-market

Air Ambulance Services Market@https://www.reportsanddata.com/report-detail/air-ambulance-services-market

Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Respiratory Inhaler Devices Market Size Analysis, DROT, PEST, Porter’s, Region & Country Forecast Till 2027 here

News-ID: 2351196 • Views:

More Releases from Reports And Data

Hybrid work models and workplace wellness initiatives increase demand for contemporary height-adjustable desks across residential and commercial settings
Hybrid work models and workplace wellness initiatives increase demand for contem …
NEW YORK, June 11, 2026 - The global Contemporary Height-Adjustable Desk market is expected to grow from USD 8.74 Billion in 2025 to USD 15.92 Billion by 2035, at a revenue CAGR of 6.2% during the forecast period. Demand for ergonomic workplace solutions continues to increase as organizations adopt hybrid work arrangements and prioritize employee well-being. Businesses and home-office users are investing in furniture designed to support movement throughout the
Expanding laboratory automation and growing demand for high-throughput testing increase adoption of microplate readers across research and diagnostics facilities
Expanding laboratory automation and growing demand for high-throughput testing i …
NEW YORK, June 11, 2026 - The global Microplate Readers market is expected to grow from USD 1.21 Billion in 2025 to USD 2.06 Billion by 2035, at a revenue CAGR of 5.5% during the forecast period. Increasing demand for high-throughput screening, molecular diagnostics, and life science research is driving adoption of microplate reader systems across laboratories worldwide. Pharmaceutical companies, academic institutions, and clinical laboratories are investing in automated analytical
Rising consumer focus on wellness and home-based relaxation solutions drives demand for massage chairs across global markets
Rising consumer focus on wellness and home-based relaxation solutions drives dem …
NEW YORK, June 11, 2026 - The global Massage Chair market is expected to grow from USD 5.43 Billion in 2025 to USD 9.82 Billion by 2035, at a revenue CAGR of 6.1% during the forecast period. Growing awareness of physical wellness, stress management, and recovery therapies is increasing demand for massage chairs in residential and commercial settings. Consumers are seeking convenient wellness solutions that can be integrated into daily
Growing creator economy and enterprise video content demand accelerate adoption of advanced video editing platforms
Growing creator economy and enterprise video content demand accelerate adoption …
The global Video Editing Software market was valued at USD 4.83 Billion in 2025 and is expected to reach USD 11.92 Billion by 2035. Demand for video editing software is increasing as businesses, content creators, media companies, and educational institutions expand digital content production activities. Rising consumption of online video content and growing adoption of social media marketing strategies are supporting market growth. According to the International Telecommunication Union (ITU),

All 5 Releases


More Releases for Inhaler

12-09-2024 | Health & Medicine
Getnews
Z!NGHA Introduces Dual-Chamber Aromatherapy Nasal Inhaler
Image: https://www.getnews.info/uploads/e696f4bdf98524eaf4f4f4bc89f2369f.jpg Miami, FL - December 09, 2024 - Z!NGHA, a new player in the wellness space, is thrilled to announce the launch of its flagship product, the Z!NGHA Double Nasal Inhaler, an innovation that combines the therapeutic benefits of aromatherapy and essential oils with the on-the-go convenience of a dual-chamber nasal inhaler. Unlike the industry standard single chamber nasal inahlers, Z!ngha offers simultaneous inhalation through both nostrils, redefining aromatherapy for
Asthma Inhaler Device Market By Type (Metered-dose inhaler, MDI with a spacer, D …
The Asthma Inhaler Device Market is expected to grow at a CAGR of 6.42% during the forecast period. The market is also expected to reach a revenue of USD 19677.54 million by the end of 2022-2030. The research report on the market for asthma inhaler devices offers analysis and insights into the numerous aspects that are anticipated to be present over the course of the forecast period as well as
Increasing Number Of Launches In Generic Version Of Budesonide Inhaler Drive The …
Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhaler is designed to provide 60 to 120 inhalations depending on the device. Increasing air population is expected to lead to high prevalence of asthma worldwide. According to World Health Organization (WHO), asthma
Oxygen Inhaler Market Size, Share, Growth & Forecast 2026
Global Oxygen Inhaler Market report focuses on Oxygen Inhaler volume and value at global level, regional level and company level. From a global perspective, this report represents the overall Oxygen Inhaler market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for
Global Digital Dose Inhaler Market Insights, Forecast
Digital Dose Inhaler is a kind of medical instrument. Digital Dose Inhaler enable patients to the number of tracking has consumed doses. The global Digital Dose Inhaler market is valued at 1790 million US$ in 2018 and will reach 3540 million US$ by the end of 2025, growing at a CAGR of 8.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the
Dry Powder Inhaler Market Report 2018: Segmentation by Product (Single Dose Dry …
Global Dry Powder Inhaler market research report provides company profile for Astrazeneca Plc., 3M Company, GlaxoSmithKline Plc, Novartis AG, Cipla Ltd., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., MannKind Corporation and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and